News

Abeona Therapeutics faces a pivotal FDA decision after a CRL-led crash and partial rebound in pz-cel’s valuation. Check out ...
A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...
Pacira Biosciences leads in non-opioid pain relief with Exparel & upcoming knee osteoarthritis therapy. Click here to read my ...
Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...
On the heels of its acquisition by Ocuphire Pharma, Opus is planning next steps for its Leber congenital amaurosis type 5 ...
Infinitopes Ltd today announces that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Clinical Trial Application (CTA) approval for the first-in-human Phase I/IIa clinical ...
A 33-year-old man arrested in Nicosia on Thursday for illegal possession of class C controlled drugs was on Friday taken before the Nicosia district court, which issued a five-day remand order.
Research on the biological basis of addiction has found that the critical epigenetic enzyme histone deacetylase 5 (HDAC5) limits the expression of the gene Scn4b, regulating neuronal activity and ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
Scientists explored selectively blocking the CYP3A4 protein responsible for breaking down large swaths of approved drugs, providing a way to improve drug efficacy.
Gene therapy companies have faced numerous setbacks over the last few years. What will it take for gene therapies to fulfill ...